Evidence map›Paper›PMID 23376190›Full record

ArticleGlycobiology2013

Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity.

Elena Ermakova, Michelle C Miller, Irina V Nesmelova, Lara López-Merino, Manuel Alvaro Berbís, Yuri Nesmelov, Yaroslav V Tkachev, Laura Lagartera, Vladimir A Daragan, Sabine André and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Galectins: Important Regulators in Normal and Pathologic Pregnancies.International journal of molecular sciences · 2022
    Review
  8. Article
  9. What is the Sugar Code?Chembiochem : a European journal of chemical biology · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Binding of a SolubleBiochemistry · 2020
    Article
  16. P53 in the impaired lungs.DNA repair · 2020
    Review
  17. Article
  18. Article
  19. Unconventional secretion of annexins and galectins.Seminars in cell & developmental biology · 2018
    Review
  20. Galectins as Molecular Targets for Therapeutic Intervention.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Elena ErmakovaDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA.
Michelle C Miller
Irina V Nesmelova
Lara López-Merino
Manuel Alvaro Berbís
Yuri Nesmelov
Yaroslav V Tkachev
Laura Lagartera
Vladimir A Daragan
Sabine André
F Javier Cañada
Jesús Jiménez-Barbero
Dolores Solís
Hans-Joachim Gabius
Kevin H Mayo
University of Minnesota · USCentro de Investigaciones Biológicas Margarita Salas · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESLudwig-Maximilians-Universität München · DEUniversity of North Carolina at Charlotte · USInstituto de Química Física Blas Cabrera · ES

Funding

TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
Peptide Based Antiagiogenic Antitumor AgentR01CA096090 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MAYO, KEVIN H. · 2002 to 2011
$2.7M
NCI NIH HHS CA 096090NCI NIH HHS T32 CA009138NHLBI NIH HHS HL 07062
6 · The paper itself

Abstract

The product of p53-induced gene 1 is a member of the galectin family, i.e., galectin-7 (Gal-7). To move beyond structural data by X-ray diffraction, we initiated the study of the lectin by nuclear magnetic resonance (NMR) and circular dichroism spectroscopies, and molecular dynamics (MD) simulations. In concert, our results indicate that lactose binding to human Gal-7 induces long-range effects (minor conformational shifts and changes in structural dynamics) throughout the protein that result in stabilization of the dimer state, with evidence for positive cooperativity. Monte Carlo fits of (15)N-Gal-7 HSQC titrations with lactose using a two-site model yield K1 = 0.9 ± 0.6 × 10(3) M(-1) and K2 = 3.4 ± 0.8 × 10(3) M(-1). Ligand binding-induced stabilization of the Gal-7 dimer was supported by several lines of evidence: MD-based calculations of interaction energies between ligand-loaded and ligand-free states, gel filtration data and hetero-FRET spectroscopy that indicate a highly reduced tendency for dimer dissociation in the presence of lactose, CD-based thermal denaturation showing that the transition temperature of the lectin is significantly increased in the presence of lactose, and saturation transfer difference (STD) NMR using a molecular probe of the monomer state whose presence is diminished in the presence of lactose. MD simulations with the half-loaded ligand-bound state also provided insight into how allosteric signaling may occur. Overall, our results reveal long-range effects on Gal-7 structure and dynamics, which factor into entropic contributions to ligand binding and allow further comparisons with other members of the galectin family.

Indexed as

Allosteric RegulationAmino Acid SequenceGalectinsHumansLactoseMolecular Dynamics SimulationMolecular Sequence DataProtein BindingProtein DenaturationProtein MultimerizationProtein StabilityGalectinsLactoseLGALS7 protein, human

Identifiers

PMID23376190
PMCPMC3608354
OpenAlexW2158988272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.